<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Surg Oncol</journal-id><journal-id journal-id-type="iso-abbrev">World J Surg Oncol</journal-id><journal-title-group><journal-title>World Journal of Surgical Oncology</journal-title></journal-title-group><issn pub-type="epub">1477-7819</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6419842</article-id><article-id pub-id-type="publisher-id">1591</article-id><article-id pub-id-type="doi">10.1186/s12957-019-1591-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Association between tea and coffee consumption and brain cancer risk: an updated meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Song</surname><given-names>Yang</given-names></name><address><email>song_yang11@yeah.net</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Zhiyun</given-names></name><address><phone>+8602223626136</phone><email>wang__zhy@yeah.net</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jin</surname><given-names>Yanyu</given-names></name><address><email>yanyu_jin2019@163.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Jie</given-names></name><address><email>guo_jjj@yeah.net</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0605 6814</institution-id><institution-id institution-id-type="GRID">grid.417024.4</institution-id><institution>Department of Neurology, </institution><institution>Tianjin First Center Hospital, </institution></institution-wrap>No. 24, Fukang Road, Nankai District, Tianjin, 300192 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0605 6814</institution-id><institution-id institution-id-type="GRID">grid.417024.4</institution-id><institution>Department of General Surgery, </institution><institution>Tianjin First Center Hospital, </institution></institution-wrap>Tianjin, 300192 China </aff></contrib-group><pub-date pub-type="epub"><day>15</day><month>3</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>3</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>17</volume><elocation-id>51</elocation-id><history><date date-type="received"><day>17</day><month>1</month><year>2019</year></date><date date-type="accepted"><day>7</day><month>3</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Previous studies had demonstrated some associations between coffee and tea consumption and brain cancer risk resulted in an inconsistent relationship. We therefore performed this study to further explore the association between them.</p></sec><sec><title>Method</title><p id="Par2">By searching PubMed, Embase, and Web of Science, we retrieved up to 1 November 2018, 11 relevant literature of publications were collected by 2 people eventually. Stata 14.0 software was used for data analysis.</p></sec><sec><title>Results</title><p id="Par3">In total, 11 articles (11 articles for coffee, 8 articles for tea, and 4 articles for coffee plus tea) were used in this meta-analysis. A statistically significant protective effect of coffee consumption and brain cancer risk was found (RR&#x02009;=&#x02009;0.785, 95% CI&#x02009;=&#x02009;0.580&#x02013;0.984, <italic>I</italic><sup>2</sup>&#x000a0;=&#x02009;65.6%, <italic>P</italic>
<sub>for heterogeneity</sub>&#x02009;=&#x02009;0.001), especially in Asian populations (RR&#x02009;=&#x02009;0.217, 95% CI&#x02009;=&#x02009;0.042&#x02013;0.896). However, the association between the risk of brain cancer and tea consumption was non-significant in the whole result (RR&#x02009;=&#x02009;0.897, 95% CI&#x02009;=&#x02009;0.739&#x02013;1.088, <italic>I</italic><sup>2</sup>&#x000a0;=&#x02009;29.9%, <italic>P</italic>
<sub>for heterogeneity</sub>&#x02009;=&#x02009;0.189), but significant in American populations (RR&#x02009;=&#x02009;0.798, 95% CI&#x02009;=&#x02009;0.646&#x02013;0.986). Interestingly, the RR was 0.684 (95% CI&#x02009;=&#x02009;0.481&#x02013;0.975) for the risk of brain cancer when compared the highest versus the lowest category consumption of coffee plus tea.</p></sec><sec><title>Conclusion</title><p id="Par4">Findings from this study suggested that higher consumption of coffee may contribute to the lower development of brain cancer in Asian populations. Tea consumption had an inverse association for the risk of brain cancer in American populations, instead of other populations.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s12957-019-1591-y) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Coffee</kwd><kwd>Tea</kwd><kwd>Brain cancer</kwd><kwd>Glioma</kwd><kwd>Meta-analysis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par8">Brain cancer is one of the most common malignant tumors in adult primary intracranial tumors [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The role of several nutritional factors in the prevention of brain cancer has been investigated. For example, consumption of fresh fruits and vegetables [<xref ref-type="bibr" rid="CR3">3</xref>], fresh fish [<xref ref-type="bibr" rid="CR4">4</xref>], and vitamin supplements [<xref ref-type="bibr" rid="CR5">5</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>] have been acted preventive agents. Coffee and tea are popular with people as two kinds of drinks. Coffee consumption had been linked to some cancers. Horisaki et al. performed a dose-response meta-analysis indicated that coffee consumption may be weakly inversely associated with the risk of colorectal cancer in Japanese [<xref ref-type="bibr" rid="CR8">8</xref>]. Previous studies published by Lukic et al. [<xref ref-type="bibr" rid="CR9">9</xref>] and Lafranconi et al. [<xref ref-type="bibr" rid="CR10">10</xref>] suggested that a prospective effect of coffee consumption on the risk of endometrial cancer. Highest versus lowest category of tea consumption had been confirmed of decreased with liver cancer [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], ovarian cancer [<xref ref-type="bibr" rid="CR13">13</xref>], gastric cancer [<xref ref-type="bibr" rid="CR14">14</xref>], oral cancer [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], and endometrial cancer [<xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par9">A previous meta-analysis was published to explore the association between coffee and tea consumption and the risk of glioma in adults [<xref ref-type="bibr" rid="CR18">18</xref>]. They concluded that the highest versus lowest category of coffee consumption, tea consumption, and coffee plus tea consumption had no effect on the risk of brain cancer. However, many studies had been published to further assess the association between coffee and tea consumption and the risk of brain cancer since that meta-analysis. For this reason, this paper increased the sample size and improved the test efficiency through an updated meta-analysis to obtain more authentic and reliable analysis results, which is helpful to clarify whether coffee or tea consumption has some inverse effects on brain cancer development, and finally provides evidence of prevention for brain cancer.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Search strategy and inclusion criteria</title><p id="Par10">Two authors independently checked the databases of PubMed, Embase, and Web of Science to find the relevant articles which investigated the association between tea and/or coffee consumption and risk of brain cancer from inception up to 1 November 2018. The following search terms were used: &#x0201c;tea&#x0201d; OR &#x0201c;coffee&#x0201d; OR &#x0201c;drinking&#x0201d; combined with &#x0201c;brain cancer&#x0201d; OR &#x0201c;brain tumor&#x0201d; OR &#x0201c;glioma.&#x0201d; To identify titles and abstracts of relevant literature, reference lists of studies were checked manually.</p><p id="Par11">All studies included in this meta-analysis should meet the following criteria: (1) assessment of the tea and/or coffee consumption and brain cancer or glioma risk; (2) observational studies; (3) the detailed data of studies must be completely provided in all participants directly or indirectly; (4) human studies.</p></sec><sec id="Sec4"><title>Data extraction</title><p id="Par12">Data were extracted independently by two researchers (YS and ZYW). All the information listed in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> in each study was abstracted carefully. The disagreements with these two researchers were resolved by discussion and consensus.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of the included studies on tea and coffee consumption and brain cancer risk</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Study, year</th><th>Country</th><th>Study design</th><th>Participants (cases)</th><th>Age (years)</th><th>Outcome</th><th>Exposure and category</th><th>RR (95% CI)</th><th>Adjustment for covariates</th></tr></thead><tbody><tr><td>Baglietto et al. 2011</td><td>Australia</td><td>Cohort</td><td>39,766 (67)</td><td>27&#x02013;81</td><td>Brain glioma</td><td>Coffee: 4 cups/day or more vs. &#x0003c;&#x02009;1cup /day</td><td>0.51 (0.20&#x02013;1.13)</td><td>Adjusted for sex, country of birth, total energy intake from diet, and level of education.</td></tr><tr><td>Burch et al. 1987</td><td>Canada</td><td>HBCC</td><td>475 (247)</td><td>25&#x02013;80</td><td>Brain cancer</td><td>Coffee: ever vs. never<break/>Tea: ever vs. never</td><td>Coffee: 1.26 (0.76&#x02013;2.09)<break/>Tea: 1.13 (0.73&#x02013;1.72)</td><td>Adjusted for age, sex, area of residence, marital status, and date of diagnosis or death.</td></tr><tr><td>Dubrow et al. 2012</td><td>USA</td><td>Cohort</td><td>545,771 (904)</td><td>50&#x02013;71</td><td>Brain glioma</td><td>Coffee: &#x02265;6 cups/day vs. none<break/>Tea: &#x0003e;&#x02009;3 cup/day vs. none<break/>Tea plus coffee: &#x0003e;&#x02009;5 cup/day vs. none</td><td>Coffee: 1.04 (0.70&#x02013;1.55)<break/>Tea: 0.75 (0.57&#x02013;1.00)<break/>Tea plus coffee:<break/>0.68 (0.46&#x02013;1.03)</td><td>Adjusted for age, sex, race/ethnicity, height, and intake of total energy, fruit, vegetable, and nitrites.</td></tr><tr><td>Efird et al. 2004</td><td>USA</td><td>Cohort</td><td>133,811 (130)</td><td>&#x02265;&#x02009;25</td><td>Brain glioma</td><td>Coffee: &#x02265;&#x02009;7 cups/day vs. &#x0003c;&#x02009;1 cup/day</td><td>1.7 (0.8&#x02013;3.6)</td><td>Adjusted for age, sex, race, smoking, education, and alcohol.</td></tr><tr><td>Hashibe et al. 2015</td><td>USA</td><td>Cohort</td><td>97,334 (103)</td><td>55&#x02013;74</td><td>Brain glioma</td><td>Coffee: &#x02265;&#x02009;2 cups/day vs. &#x0003c;&#x02009;1 cup/day<break/>Tea: &#x02265;&#x02009;1 cup/day vs. &#x0003c;&#x02009;1 cup/day</td><td>Coffee: 0.76 (0.50&#x02013;1.17)<break/>Tea: 1.04 (0.65&#x02013;1.66)</td><td>Adjusted for age (continuous), sex, race, and education.</td></tr><tr><td>Hochberg et al. 1990</td><td>USA</td><td>PBCC</td><td>288 (160)</td><td>15&#x02013;81</td><td>Brain glioma</td><td>Coffee: &#x02265;&#x02009;4 cups/day vs. &#x0003c;&#x02009;1 cup/day</td><td>0.9 (0.5&#x02013;1.8)</td><td>Adjusted for age, sex, and socio-economic status.</td></tr><tr><td>Holick et al. 2010</td><td>USA</td><td>Cohort</td><td>230,655 (335)</td><td>25&#x02013;75</td><td>Brain glioma</td><td>Coffee: &#x02265;&#x02009;4 cups/day vs. none<break/>Tea: &#x02265;&#x02009;8 cups/day vs. none<break/>Tea plus coffee: &#x02265;&#x02009;5 cups/ day vs. &#x0003c;&#x02009;1 cup/day</td><td>Coffee: 0.80 (0.54&#x02013;1.17)<break/>Tea: 0.71 (0.45&#x02013;1.12)<break/>Tea plus coffee:<break/>0.60 (0.41&#x02013;0.87)</td><td>Adjusted for age, sex, total caloric intake. (Further adjustments for cigarette smoking, current smoking, intake of processed meat, alcohol, fruit and vegetables , and, for women, reproductive factors did not change the risk estimates)</td></tr><tr><td>Malmir et al. 2017</td><td>Iran</td><td>HBCC</td><td>384 (128)</td><td>43.4&#x02009;&#x000b1;&#x02009;14.6</td><td>Brain glioma</td><td>Coffee: T3 vs. T1<break/>Tea: T3 vs. T1<break/>Tea plus coffee: T3 vs. T1</td><td>Coffee: 0.09 (0.03&#x02013;0.24)<break/>Tea: 0.33 (0.13&#x02013;0.86)<break/>Tea plus coffee:<break/>0.35 (0.15&#x02013;0.83)</td><td>Adjusted for energy intake, physical activity, family history of cancers, family history of glioma, marital status, education, highrisk occupation, high-risk residential area, duration of cell phone use, supplement use, history of exposure to the radiographic X-ray, history of head trauma, history of allergy, history of hypertension, smoking status, exposure to chemicals, drug use, personal hair dye, frequent fried food<break/>intake, frequent use of barbecue, canned foods and microwave, meats and processed meats, legumes and nuts, fruits, salt and interaction effects of tea and coffee consumption, and BMI.</td></tr><tr><td>Michaud et al. 2010</td><td>France, Italy, Spain, Denmark, Germany, Greece, Netherlands, Norway, Sweden, UK</td><td>Cohort</td><td>521,448 (343)</td><td>25&#x02013;70</td><td>Brain glioma</td><td>Coffee: Q5 vs. Q1<break/>Tea: Q4 vs. Q1<break/>Tea plus coffee: Q5 vs. Q1</td><td>Coffee: 0.98 (0.67&#x02013;1.41)<break/>Tea: 1.05 (0.75&#x02013;1.48)<break/>Tea plus coffee:<break/>1.02 (0.72&#x02013;1.44)</td><td>Adjusted for age, sex, country, body mass index, smoking status, and education.</td></tr><tr><td>Nelson et al. 2012</td><td>USA</td><td>Cohort</td><td>8006 (9)</td><td>45&#x02013;68</td><td>Brain glioma</td><td>Coffee: &#x02265;&#x02009;4 cups/day vs. none<break/>Tea: &#x02265;&#x02009;4 cups/day vs. none</td><td>Coffee: 0.89 (0.08&#x02013;10.02)<break/>Tea: 1.21 (0.22&#x02013;6.76)</td><td>Adjusted for age, education, and triceps skinfold thickness</td></tr><tr><td>Ogawa et al. 2016</td><td>Japan</td><td>Cohort</td><td>106,324 (157)</td><td>40&#x02013;69</td><td>Brain cancer<break/>Brain glioma</td><td>Coffee: &#x02265;&#x02009;3 cups/day vs. &#x02264;&#x02009;4&#x02009;days/week<break/>Tea: &#x02265;&#x02009;3 cups/day vs. &#x02264;&#x02009;4&#x02009;days/week</td><td>Brain cancer:<break/>Coffee: 0.48 (0.23&#x02013;1.00)<break/>Tea: 0.55 (0.17&#x02013;1.84)<break/>Brain glioma:<break/>Coffee: 1.07 (0.70&#x02013;1.62)<break/>Tea: 1.05 (0.54&#x02013;2.05)</td><td>Adjusted for age, sex, BMI, pack-years of cigarettes (never and past, 0&#x02013;20, &#x0003e;&#x02009;20), alcohol intake (non and past and 1&#x02013;3 times/month, drinker &#x02264;&#x02009;150, 150&#x02009;g of ethanol per week), green tea (&#x02264;&#x02009;4&#x02009;days/week, 1&#x02013;2 cups/day, &#x02265;&#x02009;3 cups/day), and past history of allergy, past history of diabetes mellitus.</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: <italic>RR</italic> relative risk, <italic>CI</italic> confidence interval, <italic>PBCC</italic> population-based case-control studies, <italic>HBCC</italic> hospital-based case-control studies, <italic>T3</italic> tertile 3, <italic>T1</italic> tertile 1, <italic>Q1</italic> quartile 1, <italic>Q4</italic> quartile 4, <italic>Q5</italic> quartile 5</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec5"><title>Statistical analysis</title><p id="Par13">Stata 14.0 software was used for data analysis. The combined relative risk (RR) with its 95% confidence interval (CI) for tea and coffee consumption and brain cancer risk were calculated. Forest plots for the association between tea and coffee consumption and brain cancer risk were mapping. Heterogeneity between studies was evaluated by chi-square-based <italic>Q</italic> test and <italic>I</italic><sup>2</sup> test [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. The random-effects model was used for all the analysis. Potential publication biases were examined using Egger&#x02019;s linear regression [<xref ref-type="bibr" rid="CR21">21</xref>] and Begg&#x02019;s funnel plots [<xref ref-type="bibr" rid="CR22">22</xref>]. Sensitivity analysis was done to estimate the stability of the results by removing a single study from the analysis. Subgroup analyses by study design and geographic location were also performed. <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant.</p></sec></sec><sec id="Sec6"><title>Results</title><sec id="Sec7"><title>Study selection and study characterization</title><p id="Par14">According to retrieval methods above, 2421 relevant studies from the databases (671 articles from PubMed, 1299 articles from Web of Science, and 451 articles from Embase) and 2 additional records identified when we reviewed the discussion and introduction of the included studies were selected. In total, 11 articles [<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref>] were included in this study, as shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. Six studies were from the USA, 1 from Australia, 1 from Canada, 1 from Iran, 1 from Japan, and 1 from Europe (France, Italy, Spain, Denmark, Germany, Greece, Netherlands, Norway, Sweden, and the UK). Eight of the 11 included studies were cohort design, and the remaining 3 studies were case-control design. The characteristics of the observational studies are shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>Flow chart of meta-analysis for exclusion/inclusion of studies</p></caption><graphic xlink:href="12957_2019_1591_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec8"><title>Coffee consumption and the risk of brain cancer</title><p id="Par15">All of the 11 included studies were used to assess the association between coffee consumption and brain cancer risk. Pooled RR suggested that highest category of coffee consumption could reduce the risk of brain cancer (RR&#x02009;=&#x02009;0.785, 95% CI&#x02009;=&#x02009;0.580&#x02013;0.984, <italic>I</italic><sup>2</sup>&#x000a0;=&#x02009;65.6%, <italic>P</italic>
<sub>for heterogeneity</sub>&#x02009;=&#x02009;0.001) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>), when compared with the lowest category. Ten of the 11 included studies were performed about coffee consumption and glioma risk, resulting in a statistically significant protective effect of coffee consumption on the risk of glioma (RR&#x02009;=&#x02009;0.760, 95% CI&#x02009;=&#x02009;0.548&#x02013;0.972). This result is showing a statistically significant protective effect of coffee consumption in the cohort studies (RR&#x02009;=&#x02009;0.858, 95% CI&#x02009;=&#x02009;0.700&#x02013;0.992), instead of case-control studies. Furthermore, we also explored whether the risk of brain cancer was related to geographic location. The results from our analysis indicated that an inverse association was only found in Asian populations (RR&#x02009;=&#x02009;0.217, 95% CI&#x02009;=&#x02009;0.042&#x02013;0.896), but not in other populations else. Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> shows the results for both whole and subgroup analyses.<fig id="Fig2"><label>Fig. 2</label><caption><p>The forest plot of the relationship between coffee consumption and the risk of brain cancer</p></caption><graphic xlink:href="12957_2019_1591_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary risk estimates of the association between tea and coffee consumption and brain cancer risk</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Subgroups</th><th colspan="4">Tea consumption (highest vs. lowest category)</th><th colspan="4">Coffee consumption (highest vs. lowest category)</th></tr><tr><th>Studies, <italic>n</italic></th><th>RR (95% CI)</th><th><italic>I</italic><sup><italic>2</italic></sup> (%)</th><th>
<italic>P</italic>
<sub>heterogeneity</sub>
</th><th>Studies, <italic>n</italic></th><th>RR (95% CI)</th><th><italic>I</italic><sup><italic>2</italic></sup> (%)</th><th>
<italic>P</italic>
<sub>heterogeneity</sub>
</th></tr></thead><tbody><tr><td>All studies</td><td>8</td><td>0.897 (0.739&#x02013;1.088)</td><td>29.9</td><td>0.189</td><td>11</td><td>0.785 (0.580&#x02013;0.984)</td><td>65.6</td><td>0.001</td></tr><tr><td>Glioma</td><td>7</td><td>0.846 (0.683&#x02013;1.047)</td><td>24.6</td><td>0.241</td><td>10</td><td>0.760 (0.548&#x02013;0.972)</td><td>63.9</td><td>0.003</td></tr><tr><td>Cohort</td><td>6</td><td>0.891 (0.755&#x02013;1.051)</td><td>0.0</td><td>0.471</td><td>8</td><td>0.858 (0.700&#x02013;0.992)</td><td>20.1</td><td>0.270</td></tr><tr><td>Case-control</td><td>2</td><td>0.658 (0.199&#x02013;2.179)</td><td>81.5</td><td>0.020</td><td>3</td><td>0.507 (0.142&#x02013;1.810)</td><td>90.1</td><td>&#x0003c;&#x02009;0.001</td></tr><tr><td>America</td><td>4</td><td>0.798 (0.646&#x02013;0.986)</td><td>0.0</td><td>0.595</td><td>6</td><td>0.912 (0.740&#x02013;1.124)</td><td>0.0</td><td>0.520</td></tr><tr><td>Europe</td><td>2</td><td>1.080 (0.828&#x02013;1.410)</td><td>0.0</td><td>0.792</td><td>2</td><td>1.070 (0.793&#x02013;1.444)</td><td>0.0</td><td>0.433</td></tr><tr><td>Asia</td><td>2</td><td>0.643 (0.205&#x02013;2.016)</td><td>79.9</td><td>0.026</td><td>2</td><td>0.217 (0.042&#x02013;0.896)</td><td>84.9</td><td>0.010</td></tr><tr><td>Oceania</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td><td>1</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr></tbody></table></table-wrap></p><p id="Par16">Based on Egger&#x02019;s test (<italic>P</italic>&#x02009;=&#x02009;0.214) and funnel plot (Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>: Figure S1), there existed no publication bias. Sensitivity analysis was done, and the pooled RR ranged from 0.738 (95% CI&#x02009;=&#x02009;0.542&#x02013;0.961) to 0.905 (95% CI&#x02009;=&#x02009;0.754&#x02013;1.088).</p></sec><sec id="Sec9"><title>Tea consumption and the risk of brain cancer</title><p id="Par17">Eight articles [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref>] were included to explore the relationship between tea consumption and brain cancer risk. Our meta-analysis result showed that there was a non-significant association between tea consumption and brain cancer risk (RR&#x02009;=&#x02009;0.897, 95% CI&#x02009;=&#x02009;0.739&#x02013;1.088, <italic>I</italic><sup>2</sup>&#x000a0;=&#x02009;29.9%, <italic>P</italic>
<sub>for heterogeneity</sub>&#x02009;=&#x02009;0.189) (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Seven of the eight included studies were about tea consumption and glioma risk. The result was consistent with the brain cancer (RR&#x02009;=&#x02009;0.846, 95% CI&#x02009;=&#x02009;0.683&#x02013;1.047). We conducted a subgroup analysis by study design (cohort studies and case-control studies). The association was non-significant in prospective studies or in case-control studies. However, when we further explored the association between brain cancer and geographic location, we found a statistically significant protective effect of tea consumption and the risk of brain cancer in American populations (RR&#x02009;=&#x02009;0.798, 95% CI&#x02009;=&#x02009;0.646&#x02013;0.986), instead of other populations. Detailed results are shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.<fig id="Fig3"><label>Fig. 3</label><caption><p>The forest plot of the relationship between tea consumption and brain cancer risk</p></caption><graphic xlink:href="12957_2019_1591_Fig3_HTML" id="MO3"/></fig></p><p id="Par18">Based on Egger&#x02019;s test (<italic>P</italic>&#x02009;=&#x02009;0.735) and funnel plot (Additional&#x000a0;file&#x000a0;<xref rid="MOESM2" ref-type="media">2</xref>: Figure S2), there existed no publication bias between tea consumption and brain cancer risk. Sensitivity analysis was done and the pooled RR ranged from 0.863 (95% CI&#x02009;=&#x02009;0.699&#x02013;1.067) to 0.947 (95% CI&#x02009;=&#x02009;0.763&#x02013;1.176).</p></sec><sec id="Sec10"><title>Coffee plus tea consumption and the risk of brain cancer</title><p id="Par19">Four studies [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>] were performed to assess the association between coffee plus tea consumption and the risk of brain cancer. Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> showed that the RR was 0.684 (95% CI&#x02009;=&#x02009;0.481&#x02013;0.975) when compared the highest versus the lowest category consumption of coffee plus tea.<fig id="Fig4"><label>Fig. 4</label><caption><p>The forest plot of the relationship between coffee plus tea consumption and brain cancer risk</p></caption><graphic xlink:href="12957_2019_1591_Fig4_HTML" id="MO4"/></fig></p></sec></sec><sec id="Sec11"><title>Discussion</title><p id="Par20">This meta-analysis included 11 publications involving 2583 cases and 1,684,262 participants to assess the association of coffee consumption, tea consumption, and coffee plus tea consumption on the risk of brain cancer. We also performed subgroup analyses by study design and geographic location to further explore the association between coffee and tea consumption and the risk of brain cancer.</p><p id="Par21">There were some differences between our meta-analysis and the study by Malerba et al. [<xref ref-type="bibr" rid="CR18">18</xref>]. First, Malerba et al. included six studies for coffee consumption, four studies for tea consumption, three studies for coffee plus tea consumption to assess the risk of adult glioma. However, we included 11 studies for coffee consumption, 8 studies for tea consumption, and 4 studies for coffee plus tea consumption, which was more than Malerba et al. Second, the results in our analysis suggested the highest versus the lowest categories coffee consumption and coffee plus tea consumption were inversely associated with the risk of brain cancer, which was different from the results of Malerba et al. However, we got a consistent result for tea consumption and the risk of brain cancer with them.</p><p id="Par22">Tea and coffee are rich in polyphenols including phenolic acids and flavonoids [<xref ref-type="bibr" rid="CR34">34</xref>], which are known for their antioxidant activity, regulation of heterogeneous metabolite enzymes, and inhibition of tumor promotion [<xref ref-type="bibr" rid="CR35">35</xref>], and have been shown to prevent cancer [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Furthermore, diterpenes and caffeic acid in coffee could protect against cancer [<xref ref-type="bibr" rid="CR38">38</xref>]. However, different tea consumed (such as green tea or black tea) and different coffee brewing method may vary on the effect of cancer [<xref ref-type="bibr" rid="CR39">39</xref>]. We did not analyze the detailed effect about the account type of tea consumed and coffee brewing method on brain cancer due to the limited information in the individual study. Therefore, further researches are warranted to explore the potential association about them.</p><p id="Par23">Sensitivity analysis for coffee and tea consumption and the risk of brain cancer was performed. For coffee consumption and brain cancer risk, the association changed from being statistically significant to not statistically significant when removed the study by Malmir et al. 2017 (RR&#x02009;=&#x02009;0.905, 95% CI&#x02009;=&#x02009;0.754&#x02013;1.088). Therefore, the result for coffee consumption and the risk of brain cancer was not stable. Future studies with large participants are warranted to further confirm this association. For tea consumption and the risk of brain cancer, the association was not significant when removed a single study one by one, with pooled RR ranged from 0.863 (95% CI&#x02009;=&#x02009;0.699&#x02013;1.067) to 0.947 (95% CI&#x02009;=&#x02009;0.763&#x02013;1.176). For coffee plus tea consumption and the risk of brain cancer, the pooled RR changed to 0.754 (95% CI&#x02009;=&#x02009;0.543&#x02013;1.045) when removed the study by Malmir et al. 2017. Thus, more relevant studies about coffee plus tea consumption and the risk of brain cancer are needed.</p><p id="Par24">Some limitations existed in our meta-analysis. First, high between-study heterogeneity existed in some results. Although meta-regression analysis was performed to explore the sources of this high between-study heterogeneity, we could not find the detailed sources of heterogeneity due to stratified analysis and meta-regression analysis concerning the relationship between coffee consumption and the risk of brain cancer. On the other hand, we used a random-effects model in all the results, which had a wider CI than the fixed-effects model. Thus, random-effects could obtain a more conservative result. Second, 3 of the 11 studies were case-control design, which could lead to some recalling bias, selective bias, and so on. However, case-control studies could also explain the relationship between coffee and tea consumption and the risk of brain cancer. Third, we could not perform the subgroup analysis by sex or lifestyle due to the limited information in each individual study. Considering sex and lifestyle may be a risk factor for coffee and/or tea consumption, future studies with detailed information about sex and lifestyle are warranted to further explore the association between coffee or tea consumption and risk of brain cancer. Fourth, the range of years in coffee or tea consumption may play a different role in the risk of brain cancer due to cancer maybe consists of various stages during aging [<xref ref-type="bibr" rid="CR40">40</xref>]. However, the information about the range of years about coffee and tea consumption in each individual study was limited.</p></sec><sec id="Sec12"><title>Conclusions</title><p id="Par25">Findings from this study suggested that higher consumption of coffee may contribute to the lower development of brain cancer in Asian populations. Tea consumption had an inverse association for the risk of brain cancer in American populations, instead of other populations. As some limitations existed in our study, future studies with detailed information about sex, lifestyle, and some other related factors are warranted to further explore the association between coffee or tea consumption and risk of brain cancer.</p></sec><sec sec-type="supplementary-material"><title>Additional files</title><sec id="Sec13"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12957_2019_1591_MOESM1_ESM.tif"><label>Additional file 1:</label><caption><p><bold>Figure S1.</bold> Funnel plot for the analysis of publication bias between coffee consumption and brain cancer risk. (TIF 40&#x000a0;kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12957_2019_1591_MOESM2_ESM.tif"><label>Additional file 2:</label><caption><p><bold>Figure S2.</bold> Funnel plot for the analysis of publication bias between tea consumption and brain cancer risk. (TIF 39&#x000a0;kb)</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CI</term><def><p id="Par5">Confidence interval</p></def></def-item><def-item><term>OR</term><def><p id="Par6">Odds ratio</p></def></def-item><def-item><term>RR</term><def><p id="Par7">Relative risk</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>None</p><sec id="FPar1"><title>Funding</title><p id="Par26">None.</p></sec><sec id="FPar2" sec-type="data-availability"><title>Availability of data and materials</title><p id="Par27">The tables and figures supporting the conclusions of this article are included within the article.</p></sec></ack><notes notes-type="author-contribution"><title>Author&#x02019;s contributions</title><p>YS conceived and designed the study. YS, ZYW, and YYJ participated in data collecting. JG analyzed data. YS and ZYW commented on drafts of the paper. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p>Not applicable.</p></sec><sec id="FPar4"><title>Consent for publication</title><p>All authors consented for publication.</p></sec><sec id="FPar5"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="FPar6"><title>Publisher&#x02019;s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>WF</given-names></name><name><surname>Niu</surname><given-names>C</given-names></name><name><surname>Shakir</surname><given-names>TM</given-names></name><etal/></person-group><article-title>An evidence-based approach to assess the accuracy of intravoxel incoherent motion imaging for the grading of brain tumors</article-title><source>Medicine (Baltimore)</source><year>2018</year><volume>97</volume><fpage>e13217</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000013217</pub-id><pub-id pub-id-type="pmid">30407363</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daumas-Duport</surname><given-names>C</given-names></name><name><surname>Scheithauer</surname><given-names>B</given-names></name><name><surname>O'Fallon</surname><given-names>J</given-names></name><etal/></person-group><article-title>Grading of astrocytomas. A simple and reproducible method</article-title><source>Cancer</source><year>1988</year><volume>62</volume><fpage>2152</fpage><lpage>2165</lpage><pub-id pub-id-type="doi">10.1002/1097-0142(19881115)62:10&#x0003c;2152::AID-CNCR2820621015&#x0003e;3.0.CO;2-T</pub-id><pub-id pub-id-type="pmid">3179928</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>Association between fruit and vegetable intake and risk for glioma: a meta-analysis</article-title><source>Nutrition</source><year>2014</year><volume>30</volume><fpage>1272</fpage><lpage>1278</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2014.03.027</pub-id><pub-id pub-id-type="pmid">25194962</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lian</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Xing</surname><given-names>B</given-names></name><etal/></person-group><article-title>Fish intake and the risk of brain tumor: a meta-analysis with systematic review</article-title><source>Nutr J</source><year>2017</year><volume>16</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/s12937-016-0223-4</pub-id><pub-id pub-id-type="pmid">28077138</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>W</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Association between dietary vitamin a intake and the risk of glioma: evidence from a meta-analysis</article-title><source>Nutrients</source><year>2015</year><volume>7</volume><fpage>8897</fpage><lpage>8904</lpage><pub-id pub-id-type="doi">10.3390/nu7115438</pub-id><pub-id pub-id-type="pmid">26516909</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Association between vitamin C intake and glioma risk: evidence from a meta-analysis</article-title><source>Neuroepidemiology</source><year>2015</year><volume>44</volume><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1159/000369814</pub-id><pub-id pub-id-type="pmid">25720916</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyritsis</surname><given-names>AP</given-names></name><name><surname>Bondy MLand Levin</surname><given-names>VA</given-names></name></person-group><article-title>Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents</article-title><source>Nutr Cancer</source><year>2011</year><volume>63</volume><fpage>174</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1080/01635581.2011.523807</pub-id><pub-id pub-id-type="pmid">21302177</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horisaki</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>H</given-names></name><etal/></person-group><article-title>A dose-response meta-analysis of coffee consumption and colorectal Cancer risk in the Japanese population: application of a cubic-spline model</article-title><source>J Epidemiol</source><year>2018</year><volume>28</volume><fpage>503</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.2188/jea.JE20170201</pub-id><pub-id pub-id-type="pmid">29863027</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukic</surname><given-names>M</given-names></name><name><surname>Guha</surname><given-names>N</given-names></name><name><surname>Licaj</surname><given-names>I</given-names></name><etal/></person-group><article-title>Coffee drinking and the risk of endometrial Cancer: an updated meta-analysis of observational studies</article-title><source>Nutr Cancer</source><year>2018</year><volume>70</volume><fpage>513</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1080/01635581.2018.1460681</pub-id><pub-id pub-id-type="pmid">29708405</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Lafranconi A, Micek A, Galvano F, et al. Coffee decreases the risk of endometrial Cancer: a dose-response meta-analysis of prospective cohort studies. Nutrients. 2017;9. 10.3390/nu9111223.</mixed-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>CX</given-names></name><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Green tea consumption and the risk of liver Cancer: a meta-analysis</article-title><source>Nutr Cancer</source><year>2017</year><volume>69</volume><fpage>211</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1080/01635581.2017.1263754</pub-id><pub-id pub-id-type="pmid">28095030</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YQ</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Min</surname><given-names>H</given-names></name><etal/></person-group><article-title>Green tea and liver cancer risk: a meta-analysis of prospective cohort studies in Asian populations</article-title><source>Nutrition</source><year>2016</year><volume>32</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2015.05.021</pub-id><pub-id pub-id-type="pmid">26412579</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhan</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Tea consumption and the risk of ovarian cancer: a meta-analysis of epidemiological studies</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>37796</fpage><lpage>37806</lpage><?supplied-pmid 28445129?><pub-id pub-id-type="pmid">28445129</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><etal/></person-group><article-title>Association between green tea intake and risk of gastric cancer: a systematic review and dose-response meta-analysis of observational studies</article-title><source>Public Health Nutr</source><year>2017</year><volume>20</volume><fpage>3183</fpage><lpage>3192</lpage><pub-id pub-id-type="doi">10.1017/S1368980017002208</pub-id><pub-id pub-id-type="pmid">28980522</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><etal/></person-group><article-title>Tea consumption is associated with decreased risk of oral cancer: a comprehensive and dose-response meta-analysis based on 14 case-control studies (MOOSE compliant)</article-title><source>Medicine (Baltimore)</source><year>2018</year><volume>97</volume><fpage>e13611</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000013611</pub-id><pub-id pub-id-type="pmid">30572470</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Association of tea consumption and the risk of oral cancer: a meta-analysis</article-title><source>Oral Oncol</source><year>2014</year><volume>50</volume><fpage>276</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.oraloncology.2013.12.014</pub-id><pub-id pub-id-type="pmid">24389399</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>JG</given-names></name><etal/></person-group><article-title>Green tea, black tea consumption and risk of endometrial cancer: a systematic review and meta-analysis</article-title><source>Arch Gynecol Obstet</source><year>2016</year><volume>293</volume><fpage>143</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1007/s00404-015-3811-1</pub-id><pub-id pub-id-type="pmid">26138307</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malerba</surname><given-names>S</given-names></name><name><surname>Galeone</surname><given-names>C</given-names></name><name><surname>Pelucchi</surname><given-names>C</given-names></name><etal/></person-group><article-title>A meta-analysis of coffee and tea consumption and the risk of glioma in adults</article-title><source>Cancer Causes Control</source><year>2013</year><volume>24</volume><fpage>267</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1007/s10552-012-0126-4</pub-id><pub-id pub-id-type="pmid">23247638</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>JP</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name><name><surname>Deeks</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Measuring inconsistency in meta-analyses</article-title><source>BMJ</source><year>2003</year><volume>327</volume><fpage>557</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1136/bmj.327.7414.557</pub-id><pub-id pub-id-type="pmid">12958120</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>JP</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name></person-group><article-title>Quantifying heterogeneity in a meta-analysis</article-title><source>Stat Med</source><year>2002</year><volume>21</volume><fpage>1539</fpage><lpage>1558</lpage><pub-id pub-id-type="doi">10.1002/sim.1186</pub-id><pub-id pub-id-type="pmid">12111919</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Davey Smith</surname><given-names>G</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><etal/></person-group><article-title>Bias in meta-analysis detected by a simple, graphical test</article-title><source>BMJ</source><year>1997</year><volume>315</volume><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1136/bmj.315.7109.629</pub-id><pub-id pub-id-type="pmid">9310563</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Begg CBand Mazumdar</surname><given-names>M</given-names></name></person-group><article-title>Operating characteristics of a rank correlation test for publication bias</article-title><source>Biometrics</source><year>1994</year><volume>50</volume><fpage>1088</fpage><lpage>1101</lpage><pub-id pub-id-type="doi">10.2307/2533446</pub-id><pub-id pub-id-type="pmid">7786990</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baglietto</surname><given-names>L</given-names></name><name><surname>Giles</surname><given-names>GG</given-names></name><name><surname>English</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Alcohol consumption and risk of glioblastoma; evidence from the Melbourne collaborative cohort study</article-title><source>Int J Cancer</source><year>2011</year><volume>128</volume><fpage>1929</fpage><lpage>1934</lpage><pub-id pub-id-type="doi">10.1002/ijc.25770</pub-id><pub-id pub-id-type="pmid">21344375</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burch</surname><given-names>JD</given-names></name><name><surname>Craib</surname><given-names>KJ</given-names></name><name><surname>Choi</surname><given-names>BC</given-names></name><etal/></person-group><article-title>An exploratory case-control study of brain tumors in adults</article-title><source>J Natl Cancer Inst</source><year>1987</year><volume>78</volume><fpage>601</fpage><lpage>609</lpage><?supplied-pmid 3104645?><pub-id pub-id-type="pmid">3104645</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubrow</surname><given-names>R</given-names></name><name><surname>Darefsky</surname><given-names>AS</given-names></name><name><surname>Freedman</surname><given-names>ND</given-names></name><etal/></person-group><article-title>Coffee, tea, soda, and caffeine intake in relation to risk of adult glioma in the NIH-AARP diet and health study</article-title><source>Cancer Causes Control</source><year>2012</year><volume>23</volume><fpage>757</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1007/s10552-012-9945-6</pub-id><pub-id pub-id-type="pmid">22457000</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efird</surname><given-names>JT</given-names></name><name><surname>Friedman</surname><given-names>GD</given-names></name><name><surname>Sidney</surname><given-names>S</given-names></name><etal/></person-group><article-title>The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors</article-title><source>J Neuro-Oncol</source><year>2004</year><volume>68</volume><fpage>57</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1023/B:NEON.0000024746.87666.ed</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashibe</surname><given-names>M</given-names></name><name><surname>Galeone</surname><given-names>C</given-names></name><name><surname>Buys</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort</article-title><source>Br J Cancer</source><year>2015</year><volume>113</volume><fpage>809</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1038/bjc.2015.276</pub-id><pub-id pub-id-type="pmid">26291054</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochberg</surname><given-names>F</given-names></name><name><surname>Toniolo</surname><given-names>P</given-names></name><name><surname>Cole</surname><given-names>P</given-names></name><etal/></person-group><article-title>Nonoccupational risk indicators of glioblastoma in adults</article-title><source>J Neuro-Oncol</source><year>1990</year><volume>8</volume><fpage>55</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1007/BF00182087</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holick</surname><given-names>CN</given-names></name><name><surname>Smith</surname><given-names>SG</given-names></name><name><surname>Giovannucci</surname><given-names>E</given-names></name><etal/></person-group><article-title>Coffee, tea, caffeine intake, and risk of adult glioma in three prospective cohort studies</article-title><source>Cancer Epidemiol Biomark Prev</source><year>2010</year><volume>19</volume><fpage>39</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-09-0732</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Malmir H, Shayanfar M, Mohammad-Shirazi M, et al. Tea and coffee consumption in relation to glioma: a case-control study. Eur J Nutr. 2017. [Epub ahead of print].</mixed-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaud</surname><given-names>DS</given-names></name><name><surname>Gallo</surname><given-names>V</given-names></name><name><surname>Schlehofer</surname><given-names>B</given-names></name><etal/></person-group><article-title>Coffee and tea intake and risk of brain tumors in the European prospective investigation into Cancer and nutrition (EPIC) cohort study</article-title><source>Am J Clin Nutr</source><year>2010</year><volume>92</volume><fpage>1145</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.3945/ajcn.2010.29876</pub-id><pub-id pub-id-type="pmid">20844074</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>JS</given-names></name><name><surname>Burchfiel</surname><given-names>CM</given-names></name><name><surname>Fekedulegn</surname><given-names>D</given-names></name><etal/></person-group><article-title>Potential risk factors for incident glioblastoma multiforme: the Honolulu heart program and Honolulu-Asia aging study</article-title><source>J Neuro-Oncol</source><year>2012</year><volume>109</volume><fpage>315</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1007/s11060-012-0895-3</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>T</given-names></name><name><surname>Sawada</surname><given-names>N</given-names></name><name><surname>Iwasaki</surname><given-names>M</given-names></name><etal/></person-group><article-title>Coffee and green tea consumption in relation to brain tumor risk in a Japanese population</article-title><source>Int J Cancer</source><year>2016</year><volume>139</volume><fpage>2714</fpage><lpage>2721</lpage><pub-id pub-id-type="doi">10.1002/ijc.30405</pub-id><pub-id pub-id-type="pmid">27560973</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scalbert</surname><given-names>A</given-names></name><name><surname>Williamson</surname><given-names>G</given-names></name></person-group><article-title>Dietary intake and bioavailability of polyphenols</article-title><source>J Nutr</source><year>2000</year><volume>130</volume><fpage>2073S</fpage><lpage>2085S</lpage><pub-id pub-id-type="doi">10.1093/jn/130.8.2073S</pub-id><pub-id pub-id-type="pmid">10917926</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frei</surname><given-names>B</given-names></name><name><surname>Higdon</surname><given-names>JV</given-names></name></person-group><article-title>Antioxidant activity of tea polyphenols in vivo: evidence from animal studies</article-title><source>J Nutr</source><year>2003</year><volume>133</volume><fpage>3275S</fpage><lpage>3284S</lpage><pub-id pub-id-type="doi">10.1093/jn/133.10.3275S</pub-id><pub-id pub-id-type="pmid">14519826</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>CS</given-names></name><name><surname>Maliakal</surname><given-names>P</given-names></name><name><surname>Meng</surname><given-names>X</given-names></name></person-group><article-title>Inhibition of carcinogenesis by tea</article-title><source>Annu Rev Pharmacol Toxicol</source><year>2002</year><volume>42</volume><fpage>25</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1146/annurev.pharmtox.42.082101.154309</pub-id><pub-id pub-id-type="pmid">11807163</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ju</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>G</given-names></name><name><surname>Lambert</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Inhibition of carcinogenesis by tea constituents</article-title><source>Semin Cancer Biol</source><year>2007</year><volume>17</volume><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2007.06.013</pub-id><pub-id pub-id-type="pmid">17686632</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavin</surname><given-names>C</given-names></name><name><surname>Holzhaeuser</surname><given-names>D</given-names></name><name><surname>Scharf</surname><given-names>G</given-names></name><etal/></person-group><article-title>Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity</article-title><source>Food Chem Toxicol</source><year>2002</year><volume>40</volume><fpage>1155</fpage><lpage>1163</lpage><pub-id pub-id-type="doi">10.1016/S0278-6915(02)00029-7</pub-id><pub-id pub-id-type="pmid">12067578</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sachinidis</surname><given-names>A</given-names></name><name><surname>Seul</surname><given-names>C</given-names></name><name><surname>Seewald</surname><given-names>S</given-names></name><etal/></person-group><article-title>Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma</article-title><source>FEBS Lett</source><year>2000</year><volume>471</volume><fpage>51</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(00)01360-0</pub-id><pub-id pub-id-type="pmid">10760511</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>DJ</given-names></name><name><surname>Peleg</surname><given-names>S</given-names></name></person-group><article-title>Biphasic modeling of mitochondrial metabolism dysregulation during aging</article-title><source>Trends Biochem Sci</source><year>2017</year><volume>42</volume><fpage>702</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2017.06.005</pub-id><pub-id pub-id-type="pmid">28669456</pub-id></element-citation></ref></ref-list></back></article>